These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study. McEvoy JP; Stiller RL; Farr R J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363 [TBL] [Abstract][Full Text] [Related]
6. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M Encephale; 1995; 21(6):417-24. PubMed ID: 8674466 [TBL] [Abstract][Full Text] [Related]
7. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
8. Blood levels of haloperidol in schizophrenic patients. Shvartsburd A; Dekirmenjian H; Smith RC J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528 [TBL] [Abstract][Full Text] [Related]
9. Serum haloperidol concentrations and clinical response in acute psychosis. Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996 [TBL] [Abstract][Full Text] [Related]
10. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients. Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; Kaneko S J Clin Psychopharmacol; 2003 Oct; 23(5):435-40. PubMed ID: 14520118 [TBL] [Abstract][Full Text] [Related]
11. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects]. Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089 [TBL] [Abstract][Full Text] [Related]
12. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases]. Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R Encephale; 1987; 13(3):127-30. PubMed ID: 3595515 [TBL] [Abstract][Full Text] [Related]
13. Influence of route of administration on haloperidol plasma levels in psychotic patients. Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678 [TBL] [Abstract][Full Text] [Related]
14. Blood levels of haloperidol and clinical outcome in schizophrenia. Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415 [TBL] [Abstract][Full Text] [Related]
15. Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients. LLerena A; de la Rubia A; Berecz R; Dorado P Pharmacopsychiatry; 2004 Mar; 37(2):69-73. PubMed ID: 15048614 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders. Gerlach M; Hünnerkopf R; Rothenhöfer S; Libal G; Burger R; Clement HW; Fegert JM; Wewetzer Ch; Mehler-Wex C Pharmacopsychiatry; 2007 Mar; 40(2):72-6. PubMed ID: 17447177 [TBL] [Abstract][Full Text] [Related]
17. Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients. de Mendonça Lima CA; Baumann P; Brawand-Amey M; Brogli C; Jacquet S; Cochard N; Powell-Golay K; Eap CB Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):952-6. PubMed ID: 16006029 [TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients. Ulrich S; Sandmann U; Genz A Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420 [TBL] [Abstract][Full Text] [Related]
19. Steady-state plasma level prediction for haloperidol from a single test dose. Javaid JI; Janicak PG; Hedeker D; Sharma RP; Davis JM Psychopharmacol Bull; 1991; 27(1):83-8. PubMed ID: 1862210 [TBL] [Abstract][Full Text] [Related]
20. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients. Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]